PubRank

A Walan

Author PubWeight™ 65.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000 5.40
2 Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978 3.69
3 Cimetidine in the treatment of active duodenal and prepyloric ulcers. Lancet 1976 3.61
4 Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 2007 2.66
5 The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. Br J Clin Pharmacol 1979 1.59
6 A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol 1986 1.46
7 Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol 1984 1.44
8 Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004 1.24
9 IgA anti-gliadin antibodies and jejunal mucosal lesions in healthy blood donors. Lancet 1986 1.12
10 Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter 2000 1.12
11 Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol 1981 1.08
12 On the prevalence of adult coeliac disease in Sweden. Scand J Gastroenterol 1981 1.07
13 Vagal function in patients with diabetic neuropathy. Acta Med Scand 1972 1.07
14 Serum folate determinations in tracing adult coeliacs. Scand J Gastroenterol 1981 1.05
15 The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol 1982 1.04
16 Cimetidine, but not oxmetidine, penetrates into the cerebrospinal fluid after a single intravenous dose. Br J Clin Pharmacol 1982 1.02
17 The effects of cimetidine (Tagamet) on renal function in patients with renal failure. Acta Med Scand 1980 1.01
18 Polymyositis and adult coeliac disease. Acta Neurol Scand 1982 0.99
19 Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther 2006 0.98
20 Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine. Scand J Gastroenterol Suppl 1979 0.98
21 Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers. Lancet 1984 0.98
22 The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study. Scand J Gastroenterol 1974 0.97
23 Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole. Br J Clin Pharmacol 1998 0.95
24 Gluten-free diet for dermatitis herpetiformis: the long-term effect on cutaneous, immunological and jejunal manifestations. Acta Derm Venereol 1981 0.95
25 Food-stimulated acid secretion measured by intragastric titration with bicarbonate in patients with duodenal and gastric ulcer disease and in controls. Scand J Gastroenterol 1978 0.94
26 Long-term treatment with cimetidine in duodenal ulceration. Lancet 1977 0.92
27 Two-year follow-up after one year's treatment with cimetidine or placebo. Lancet 1980 0.90
28 High gastric bile acid concentration in prepyloric ulcer patients. Scand J Gastroenterol 1985 0.89
29 Antacids and anticholinergics in the treatment of duodenal ulcer. Clin Gastroenterol 1984 0.89
30 Inhibition of pentagastrin-induced gastric acid secretion in man by glucagon given intravenously. Scand J Gastroenterol 1969 0.87
31 Effect of cimetidine and oxmetidine on 24-h gastric acid and pepsin in patients. Scand J Gastroenterol 1983 0.87
32 No detectable concentrations of oxmetidine but measurable concentrations of cimetidine in cerebrospinal fluid (CSF) during multiple dose treatment. Br J Clin Pharmacol 1984 0.86
33 Studies on peptic ulcer disease with special reference to the effect of l-hyoscyamine. Acta Med Scand Suppl 1970 0.86
34 Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clin Pharmacokinet 1981 0.86
35 Omeprazole. Baillieres Clin Gastroenterol 1988 0.85
36 Metabolic consequences of reduced gastric acidity. Scand J Gastroenterol Suppl 1985 0.85
37 Intravenous omeprazole: effect of a loading dose on 24-h intragastric pH. Aliment Pharmacol Ther 1990 0.83
38 Influence of food on the effect of propantheline and L-hyoscyamine on salivation. Scand J Gastroenterol 1977 0.83
39 The effect of 20 Mg omeprazole daily on serum gastrin, 24-h intragastric acidity, and bile acid concentration in duodenal ulcer patients. Scand J Gastroenterol 1987 0.83
40 Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci 1995 0.82
41 Maintenance cimetidine for up to three years. Lancet 1985 0.82
42 Diminished absorption of cimetidine caused by antacids. Lancet 1979 0.81
43 Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987 0.81
44 In vivo studies on the neutralizing effect of antacids using the Heidelberg capsule. Scand J Gastroenterol 1975 0.81
45 Variation of disaccharidase activities in duodenal biopsy specimens. Scand J Gastroenterol 1986 0.81
46 Effect of 1-hyoscyamine on gastric secretion of acid and intrinsic factor in man. Gut 1967 0.81
47 Reversal of psychopathology in adult coeliac disease with the aid of pyridoxine (vitamin B6). Scand J Gastroenterol 1983 0.80
48 Letter: Gluten-sensitive polymyositis and enteropathy. Lancet 1976 0.80
49 The effect of 1-hyoscyamine in tablets with sustained release on gastric secretion of acid in man. Acta Med Scand 1965 0.80
50 Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors. Scand J Gastroenterol Suppl 1986 0.80
51 Pharmacokinetics of [14C]omeprazole in patients with impaired renal function. Clin Pharmacol Ther 1986 0.79
52 Gastric secretion of acid and intrinsic factor in patients with hyper- and hypothyroidism. Acta Med Scand 1969 0.79
53 Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. Scand J Gastroenterol 1986 0.77
54 Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Scand J Rheumatol 2001 0.77
55 Safety experience from long-term treatment with omeprazole. Digestion 1992 0.76
56 Similar prevalence of coeliac disease in children and middle-aged adults in a district of Sweden. Gut 1983 0.76
57 24-H study of gastric acidity and bile acid concentration after parietal cell vagotomy. Scand J Gastroenterol 1986 0.76
58 [Clinical value of the gastric secretory test]. Nord Med 1971 0.76
59 Omeprazole and the metabolism of caffeine. Am J Gastroenterol 1995 0.75
60 Modified sham feeding test after parietal cell vagotomy for juxtapyloric ulcer disease in patients with and without recurrent ulcers. Scand J Gastroenterol 1987 0.75
61 Gastric secretion of acid after intravenous infusion of histamine in large doses. Acta Med Scand 1967 0.75
62 [Current medical treatment of ulcer disease]. Lakartidningen 1984 0.75
63 [Intestinal and metabolic complications of atrophic gastritis]. Lakartidningen 1978 0.75
64 Duodenal, prepyloric, and combined duodenal/prepyloric ulcer disease: three distinct entities of juxtapyloric ulcer disease? Scand J Gastroenterol 1986 0.75
65 Correlation between radiological findings in the stomach and duodenum and gastric secretion in patients with peptic ulcer disease. Scand J Gastroenterol 1970 0.75
66 Therapeutic plasma concentrations of cimetidine in normal renal function and dosage requirements in renal failure. Ther Drug Monit 1980 0.75
67 Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses. Eur J Clin Pharmacol 1983 0.75
68 Pancreatic tumour with diarrhoea, hypokalemia and hypochlorhydria. Report of a case, with clinical, radiological and histopathological studies. Acta Chir Scand 1972 0.75
69 Anticholinergics in the treatment of peptic ulcer. Scand J Gastroenterol Suppl 1979 0.75
70 Gastric secretion of acid and intrinsic factor during histamine infusion in 14 cases of duodenal ulcer. Scand J Haematol 1967 0.75
71 Cimetidine and active duodenal and prepyloric ulcers. Scand J Gastroenterol Suppl 1976 0.75
72 [Ulcers. IV. A gastric juice secretion test]. Lakartidningen 1966 0.75
73 The rate of healing of duodenal ulcers during omeprazole treatment. Scand J Gastroenterol 1985 0.75
74 The effect of 1-hyoscyamine on gastric secretion of acid and pepsin in man. Scand J Gastroenterol 1969 0.75
75 [Lactose intolerance and gastrointestinal disturbances in adults]. Lakartidningen 1970 0.75
76 [Clinical trial of drugs (5): trial of drugs against diseases in the gastrointestinal canal]. Lakartidningen 1970 0.75
77 [Clinical effect of salazosulfapyridine (salazopyrin) in Crohn's disease. A controlled double-blind investigation]. Ugeskr Laeger 1974 0.75
78 [Ulcers. 8. Antacid treatment]. Lakartidningen 1966 0.75
79 Repeated pentagastrin-stimulated gastric acid secretory tests carried out in the evaluation of the pharmacodynamics of a new histamine H2-receptor antagonist, SK&F 93479. Scand J Gastroenterol 1984 0.75
80 Prevention of ulcer recurrence--medical vs surgical treatment. The physician's view. Scand J Gastroenterol Suppl 1985 0.75
81 [Anticholinergic therapy of gastric ulcers]. Lakartidningen 1971 0.75
82 Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid. Scand J Gastroenterol 1988 0.75
83 Antacids in the treatment of peptic ulcer. Acta Med Scand 1967 0.75
84 [Ulcers. VI. Medical treatment]. Lakartidningen 1966 0.75
85 [Cimetidine--mostly positive experiences after 5 years]. Lakartidningen 1981 0.75
86 Inhibition of basal gastric acid secretion in man by glucagon given intraportally. Scand J Gastroenterol 1970 0.75
87 [A case of intestinal hemorrhage]. Lakartidningen 1965 0.75
88 [Selective medical and surgical treatment of duodenal ulcer]. Lakartidningen 1977 0.75
89 The effect of 1-hyoscyamine on pentagastrin-induced secretion of acid and pepsin in man. Scand J Gastroenterol 1970 0.75
90 Gastric acid secretory response to pentagastrin infusion in diabetes mellitus. Acta Med Scand 1973 0.75
91 Intrinsic factor secretion following pentagastrin and insulin stimulation in diabetes mellitus. Acta Med Scand 1972 0.75
92 Steady-state kinetics and dosage requirements of cimetidine in renal failure. Clin Pharmacokinet 1981 0.75
93 Reappraisal of antimuscarinic drugs in the treatment of peptic ulcer disease. Scand J Gastroenterol Suppl 1982 0.75
94 Metabolic side-effects and interactions. Scand J Gastroenterol Suppl 1982 0.75
95 [Ulcers. V. Gastroscopy]. Lakartidningen 1966 0.75
96 Gastric emptying in patients with achlorhydria or hyposecretion of hydrochloric acid. Scand J Gastroenterol 1973 0.75
97 [Long term effect of ipratropium bromide on gastric secretion]. Arzneimittelforschung 1978 0.75
98 Treatment of duodenal ulcer disease. Clinical results with omeprazole. Scand J Gastroenterol Suppl 1986 0.75
99 [Endocrinologically active pancreatic neoplasms]. Lakartidningen 1971 0.75
100 Treatment of active prepyloric and duodenal ulcers with antacid/anticholinergic, cimetidine and placebo. Scand J Gastroenterol Suppl 1982 0.75
101 Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease. Can J Gastroenterol 1999 0.75